Advertisement

Complementary and Integrative Medicine for Episodic Migraine: an Update of Evidence from the Last 3 Years

  • Rebecca Erwin WellsEmail author
  • Justin Beuthin
  • Laura Granetzke
Episodic Migraine (S. Nahas, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Episodic Migraine

Abstract

Purpose of Review

The purpose of this review is to evaluate evidence from the last 3 years on complementary and integrative medicine treatment options for episodic migraine. Using Pubmed, Embase, and Cochrane databases, research published from 2015-2018 evaluating the modalities of mind/body therapies, supplements, and manual therapies for treatment of migraine were assessed.

Recent Findings

Although many studies had major methodological challenges that limit interpretation, several studies reported decreased headache frequency, improved quality of life, or less affective responses to pain. The evidence is currently most promising for the mind/body treatment options of mindfulness, yoga, and tai chi. Mindfulness meditation may be as effective as pharmacological treatment for medication-overuse headache after the offending medication is withdrawn. While older research has shown magnesium, riboflavin, feverfew, and butterbur to be helpful in migraine treatment, new research is promising to suggest potential benefit with melatonin, vitamin D, higher dosages of vitamin B6 (80 mg)/folic acid 5 mg combinations, and the combination of magnesium 112.5 mg/CoQ10 100 mg/feverfew 100 mg. Omega 3s have limited evidence of efficacy in migraine. Butterbur needs to be free of pyrrolizidine alkaloids (PA) to ensure safety given their hepatotoxicity. Physical therapy (PT) continues to have strong evidence of support, and acupuncture is superior to sham acupuncture and placebo. Side effects and risks reported were minimal and well tolerated overall, with the exception of the life-threatening risk of cervical artery dissection with high-velocity chiropractic manipulation and hepatotoxicity with the PAs in butterbur. Several studies are ongoing to further evaluate mindfulness, melatonin, PT, exercise, chiropractic manipulation, and acupuncture. The American Academy of Neurology (AAN) and American Headache Society (AHS) are currently updating the guidelines for integrative treatment options for migraine, so additional recommendations may be available soon.

Summary

In conclusion, many complementary and integrative treatment options may be helpful for patients with migraines, and understanding potential efficacy, benefits, and risks can help providers discuss these modalities with their patients. Such a conversation can empower patients, build the therapeutic relationship, and increase self-efficacy, thus improving outcomes and patient-centered care.

Keywords

Complementary and integrative medicine Migraine Mindfulness Supplements Acupuncture 

Notes

Acknowledgements

Dr. Wells is supported by the National Center For Complementary & Integrative Health (NCCIH) of the National Institutes of Health under Award Number K23AT008406. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We gratefully acknowledge the assistance of Nicholas Contillo for his tremendous help in researching recent publications. We also gratefully acknowledge the editorial assistance of Karen Klein, MA, in the Wake Forest Clinical and Translational Science Institute, funded by the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001420.

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Wells RE, Bertisch SM, Buettner C, Phillips RS, McCarthy EP. Complementary and alternative medicine use among adults with migraines/severe headaches. Headache. 2011;51(7):1087–97.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Zhang Y, Dennis JA, Leach MJ, Bishop FL, Cramer H, Chung VCH, et al. Complementary and alternative medicine use among US adults with headache or migraine: results from the 2012 National Health Interview Survey. Headache. 2017;57(8):1228–42.PubMedGoogle Scholar
  3. 3.
    Smitherman TA, Wells RE, Ford SG. Emerging behavioral treatments for migraine. Curr Pain Headache Rep. 2015;19(4):13.PubMedGoogle Scholar
  4. 4.
    Millstine D, Chen CY, Bauer B. Complementary and integrative medicine in the management of headache. BMJ. 2017;357:j1805.PubMedGoogle Scholar
  5. 5.
    Wells RE, Baute V, Wahbeh H. Complementary and integrative medicine for neurologic conditions. Med Clin North Am. 2017 Sep;101(5):881–93.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Feuille M, Pargament K. Pain, mindfulness, and spirituality: a randomized controlled trial comparing effects of mindfulness and relaxation on pain-related outcomes in migraineurs. J Health Psychol. 2015;20(8):1090–106.PubMedGoogle Scholar
  7. 7.
    Wachholtz AB, Malone CD, Pargament KI. Effect of different meditation types on migraine headache medication use. Behav Med Wash DC. 2017;43(1):1–8.Google Scholar
  8. 8.
    Bakhshani NM, Amirani A, Amirifard H, Shahrakipoor M. The effectiveness of mindfulness-based stress reduction on perceived pain intensity and quality of life in patients with chronic headache. Glob J Health Sci. 2015;8(4):142–51.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Andrasik F, Grazzi L, D’Amico D, Sansone E, Leonardi M, Raggi A, et al. Mindfulness and headache: a “new” old treatment, with new findings. Cephalalgia Int J Headache. 2016;36(12):1192–205.Google Scholar
  10. 10.
    Grazzi L, D’Amico D, Raggi A, Leonardi M, Ciusani E, Corsini E, et al. Mindfulness and pharmacological prophylaxis have comparable effect on biomarkers of inflammation and clinical indexes in chronic migraine with medication overuse: results at 12 months after withdrawal. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2017;38(Suppl 1):173–5.Google Scholar
  11. 11.
    Grazzi L, Raggi A, D’Amico D, Sansone E, Leonardi M, Andrasik F, et al. A prospective pilot study of the effect on catecholamines of mindfulness training vs pharmacological prophylaxis in patients with chronic migraine and medication overuse headache. Cephalalgia Int J Headache. 2018;13:333102418801584.Google Scholar
  12. 12.
    Grazzi L, Sansone E, Raggi A, D’Amico D, De Giorgio A, Leonardi M, et al. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with chronic migraine: an effectiveness trial with a one-year follow-up. J Headache Pain. 2017;18(1):15.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Keller A, Meyer B, Wöhlbier H-G, Overath CH, Kropp P. Migraine and meditation: characteristics of cortical activity and stress coping in migraine patients, meditators and healthy controls-an exploratory cross-sectional study. Appl Psychophysiol Biofeedback. 2016;41(3):307–13.PubMedGoogle Scholar
  14. 14.
    Komandur B, Martin PR, Bandarian-Balooch S. Mindfulness and chronic headache/migraine: mechanisms explored through the fear-avoidance model of chronic pain. Clin J Pain. 2018;34(7):638–49.PubMedGoogle Scholar
  15. 15.
    Azam MA, Katz J, Mohabir V, Ritvo P. Individuals with tension and migraine headaches exhibit increased heart rate variability during post-stress mindfulness meditation practice but a decrease during a post-stress control condition - a randomized, controlled experiment. Int J Psychophysiol Off J Int Organ Psychophysiol. 2016;110:66–74.Google Scholar
  16. 16.
    •• Gu Q, Hou J-C, Fang X-M. Mindfulness meditation for primary headache pain: a meta-analysis. Chin Med J (Engl). 2018;131(7):829–38 An important meta-analyses of mindfulness for headaches with ten studies ( n =315) that showed that mindfulness meditation significantly improved pain intensity and headache frequency. Google Scholar
  17. 17.
    Anheyer D, Leach MJ, Klose P, Dobos G, Cramer H. Mindfulness-based stress reduction for treating chronic headache: a systematic review and meta-analysis. Cephalalgia Int J Headache. 2018;1:333102418781795.Google Scholar
  18. 18.
    Kisan R, Sujan M, Adoor M, Rao R, Nalini A, Kutty BM, et al. Effect of yoga on migraine: a comprehensive study using clinical profile and cardiac autonomic functions. Int J Yoga. 2014;7(2):126–32.PubMedPubMedCentralGoogle Scholar
  19. 19.
    Naji-Esfahani H, Zamani M, Marandi SM, Shaygannejad V, Javanmard SH. Preventive effects of a three-month yoga intervention on endothelial function in patients with migraine. Int J Prev Med. 2014;5(4):424–9.PubMedPubMedCentralGoogle Scholar
  20. 20.
    John PJ, Sharma N, Sharma CM, Kankane A. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache. 2007;47(5):654–61.PubMedGoogle Scholar
  21. 21.
    Sharma VM, Manjunath NK, Nagendra HR, Ertsey C. Combination of ayurveda and yoga therapy reduces pain intensity and improves quality of life in patients with migraine headache. Complement Ther Clin Pract. 2018;32:85–91.Google Scholar
  22. 22.
    Boroujeni MZ, Marandi SM, Esfarjani F, Sattar M, Shaygannejad V, Javanmard SH. Yoga intervention on blood NO in female migraineurs. Adv Biomed Res. 2015;4:259.Google Scholar
  23. 23.
    Xie YJ, Hui SS-C, Ho SC, Suen LKP. The effectiveness of 12-week tai chi training in the prophylaxis of episodic migraine: a pilot randomized controlled trial in Chinese women. Cephalalgia. 2017;37:334.Google Scholar
  24. 24.
    Xie Y, Sai-Chuen Hui S, Ho S, Suen L. The effectiveness of 12-week TAI CHI training on the migraine attack days, body composition, and blood pressure in Chinese women with episodic migraine: a randomized controlled trial | Cochrane Library. In: Circulation [Internet]. 2018 [cited 2018 Oct 17]. Available from: https://www.cochranelibrary.com/content?templateType=full&urlTitle=/central/doi/10.1002/central/CN-01573282&doi=10.1002/central/CN-01573282&type=central&contentLanguage=&highlightAbstract=mind&highlightAbstract=migraine&highlightAbstract=migrain&highlightAbstract=mindfulness. Accessed 17 Oct 2018
  25. 25.
    Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E, et al. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012 Apr 24;78(17):1346–53.PubMedPubMedCentralGoogle Scholar
  26. 26.
    •• Diener H, Freitag F, Danesch U. Safety profile of a special butterbur extract from Petasites hybridus in migraine prevention with emphasis on the liver. Cephalalgia Rep. 2018;1:2515816318759304 An excellent review of the butterbur root extract Petadolex and its safety and risks.Google Scholar
  27. 27.
    Gaul C, Diener H-C, Danesch U, Migravent® Study Group. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain. 2015;16:516.PubMedGoogle Scholar
  28. 28.
    Guilbot A, Bangratz M, Ait Abdellah S, Lucas C. A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med. 2017;17(1):433.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Menon S, Nasir B, Avgan N, Ghassabian S, Oliver C, Lea R, et al. The effect of 1 mg folic acid supplementation on clinical outcomes in female migraine with aura patients. J Headache Pain. 2016;17(1):60.PubMedPubMedCentralGoogle Scholar
  30. 30.
    Askari G, Nasiri M, Mozaffari-Khosravi H, Rezaie M, Bagheri-Bidakhavidi M, Sadeghi O. The effects of folic acid and pyridoxine supplementation on characteristics of migraine attacks in migraine patients with aura: a double-blind, randomized placebo-controlled, clinical trial. Nutr Burbank Los Angel Cty Calif. 2017;38:74–9.Google Scholar
  31. 31.
    Sadeghi O, Nasiri M, Maghsoudi Z, Pahlavani N, Rezaie M, Askari G. Effects of pyridoxine supplementation on severity, frequency and duration of migraine attacks in migraine patients with aura: a double-blind randomized clinical trial study in Iran. Iran J Neurol. 2015;14(2):74–80.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Gonçalves AL, Martini Ferreira A, Ribeiro RT, Zukerman E, Cipolla-Neto J, Peres MFP. Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention. J Neurol Neurosurg Psychiatry. 2016;87(10):1127–32.PubMedPubMedCentralGoogle Scholar
  33. 33.
    Bougea A, Spantideas N, Lyras V, Avramidis T, Thomaidis T. Melatonin 4 mg as prophylactic therapy for primary headaches: a pilot study. Funct Neurol. 2016;31(1):33–7.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Fallah R, Fazelishoroki F, Sekhavat L. A randomized clinical trial comparing the efficacy of melatonin and amitriptyline in migraine prophylaxis of children. Iran J Child Neurol. 2018;12(1):47–54.PubMedPubMedCentralGoogle Scholar
  35. 35.
    Iannacchero R, Costa A, Squillace A, Gallelli L, Cannistrà U, De Sarro G. P060. Vitamin D deficiency in episodic migraine, chronic migraine and medication-overuse headache patients. J Headache Pain. 2015;16(Suppl 1):A184.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Celikbilek A, Gocmen AY, Zararsiz G, Tanik N, Ak H, Borekci E, et al. Serum levels of vitamin D, vitamin D-binding protein and vitamin D receptor in migraine patients from Central Anatolia region. Int J Clin Pract. 2014 Oct;68(10):1272–7.PubMedGoogle Scholar
  37. 37.
    Kjaergaard M, Eggen AE, Mathiesen EB, Jorde R. Association between headache and serum 25-hydroxyvitamin D: the Tromsø Study: Tromsø 6. Headache. 2012;52(10):1499–505.PubMedGoogle Scholar
  38. 38.
    Zandifar A, Masjedi SS, Banihashemi M, Asgari F, Manouchehri N, Ebrahimi H, et al. Vitamin D status in migraine patients: a case-control study. Biomed Res Int. 2014;2014:514782.PubMedPubMedCentralGoogle Scholar
  39. 39.
    Donmez A, Orun E, Sonmez FM. Vitamin D status in children with headache: a case-control study. Clin Nutr ESPEN. 2018;23:222–7.PubMedGoogle Scholar
  40. 40.
    Buettner C, Burstein R. Association of statin use and risk for severe headache or migraine by serum vitamin D status: a cross-sectional population-based study. Cephalalgia Int J Headache. 2015;35(9):757–66.Google Scholar
  41. 41.
    Mottaghi T, Askari G, Khorvash F, Maracy MR. Effect of vitamin D supplementation on symptoms and C-reactive protein in migraine patients. J Res Med Sci Off J Isfahan Univ Med Sci. 2015;20(5):477–82.Google Scholar
  42. 42.
    • Gazerani P, Fuglsang R, Pedersen JG, Sørensen J, Kjeldsen JL, Yassin H, et al. A randomized, double-blinded, placebo-controlled, parallel trial of vitamin D3 supplementation in adult patients with migraine. Curr Med Res Opin. 2018;28:1–9 A randomized controlled trial that demonstrated Vitamin D supplementation may improve migraines even in those without low levels at baseline.Google Scholar
  43. 43.
    Martins LB, Rodrigues AMDS, Rodrigues DF, Dos Santos LC, Teixeira AL, Ferreira AVM. Double-blind placebo-controlled randomized clinical trial of ginger ( Zingiber officinale Rosc.) addition in migraine acute treatment. Cephalalgia. 2018;0(0):1–9.Google Scholar
  44. 44.
    Maghsoumi-Norouzabad L, Mansoori A, Abed R, Shishehbor F. Effects of omega-3 fatty acids on the frequency, severity, and duration of migraine attacks: a systematic review and meta-analysis of randomized controlled trials. Nutr Neurosci. 2018;21(9):614–23.PubMedGoogle Scholar
  45. 45.
    Soares A de A, Louçana PMC, Nasi EP, Sousa KM de H, Sá OM de S, Silva-Néto RP. A doubleblind, randomized, and placebo-controlled clinical trial with omega-3 polyunsaturated fatty acids (OPFA ɷ-3) for the prevention of migraine in chronic migraine patients using amitriptyline. Nutr Neurosci. 2018;21(3):219–23.Google Scholar
  46. 46.
    D’Andrea G, Bussone G, Allais G, Aguggia M, D’Onofrio F, Maggio M, et al. Efficacy of Ginkgolide B in the prophylaxis of migraine with aura. Neurol Sci. 2009;30(1):121–4.Google Scholar
  47. 47.
    Esposito M, Carotenuto M. Ginkgolide B complex efficacy for brief prophylaxis of migraine in school-aged children: an open-label study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2011;32(1):79–81.Google Scholar
  48. 48.
    Bevilaqua-Grossi D, Gonçalves MC, Carvalho GF, Florencio LL, Dach F, Speciali JG, et al. Additional effects of a physical therapy protocol on headache frequency, pressure pain threshold, and improvement perception in patients with migraine and associated neck pain: a randomized controlled trial. Arch Phys Med Rehabil. 2016;97(6):866–74.PubMedGoogle Scholar
  49. 49.
    Espí-López G-V, Ruescas-Nicolau M-A, Nova-Redondo C, Benítez-Martínez JC, Dugailly P-M, Falla D. Effect of soft tissue techniques on headache impact, disability, and quality of life in migraine sufferers: a pilot study. J Altern Complement Med [Internet]. 2018. [cited 2018 May 15]; Available from:  https://doi.org/10.1089/acm.2018.0048
  50. 50.
    Cerritelli F, Ginevri L, Messi G, Caprari E, Di Vincenzo M, Renzetti C, et al. Clinical effectiveness of osteopathic treatment in chronic migraine: 3-armed randomized controlled trial. Complement Ther Med. 2015;23(2):149–56.PubMedGoogle Scholar
  51. 51.
    D’Ippolito M, Tramontano M, Buzzi MG. Effects of osteopathic manipulative therapy on pain and mood disorders in patients with high-frequency migraine. J Am Osteopath Assoc. 2017;117(6):365–9.PubMedGoogle Scholar
  52. 52.
    Chaibi A, Benth JŠ, Tuchin PJ, Russell MB. Chiropractic spinal manipulative therapy for migraine: a three-armed, single-blinded, placebo, randomized controlled trial. Eur J Neurol. 2017;24(1):143–53.PubMedGoogle Scholar
  53. 53.
    Kelly Kennel, Megan Daghfal, Shyam Patel. Cervical artery dissection related to chiropractic manipulation: One institution’s experience. J Fam Pract [Internet]. 2017 1 [cited 2018 Sep 24];66(9). Available from: https://www.mdedge.com/jfponline/article/145467/pain/cervical-artery-dissection-related-chiropractic-manipulation-one
  54. 54.
    Turner RC, Lucke-Wold BP, Boo S, Rosen CL, Sedney CL. The potential dangers of neck manipulation & risk for dissection and devastating stroke: An illustrative case & review of the literature. Biomed Res Rev. 2018;2(1).Google Scholar
  55. 55.
    Irby MB, Bond DS, Lipton RB, Nicklas B, Houle TT, Penzien DB. Aerobic exercise for reducing migraine burden: mechanisms, markers, and models of change processes. Headache. 2016;56(2):357–69.PubMedGoogle Scholar
  56. 56.
    Krøll LS, Sjödahl Hammarlund C, Gard G, Jensen RH, Bendtsen L. Has aerobic exercise effect on pain perception in persons with migraine and coexisting tension-type headache and neck pain? A randomized, controlled, clinical trial. Eur J Pain. 2018;22:1399–1408.Google Scholar
  57. 57.
    Linde K, Allais G, Brinkhaus B, Fei Y, Mehring M, Vertosick EA, et al. Acupuncture for the prevention of episodic migraine. Cochrane Database Syst Rev. 2016;6:CD001218.Google Scholar
  58. 58.
    Yang Y, Que Q, Ye X, Zheng G. Hua. Verum versus sham manual acupuncture for migraine: a systematic review of randomised controlled trials. Acupunct Med J Br Med Acupunct Soc. 2016;34(2):76–83.Google Scholar
  59. 59.
    Xu J, Zhang F-Q, Pei J, Ji J. Acupuncture for migraine without aura: a systematic review and meta-analysis. J Integr Med. 2018;16(5):312–21.PubMedGoogle Scholar
  60. 60.
    Zhao L, Chen J, Li Y, Sun X, Chang X, Zheng H, et al. The long-term effect of acupuncture for migraine prophylaxis: a randomized clinical trial. JAMA Intern Med. 2017;177:508–15.PubMedGoogle Scholar
  61. 61.
    Wang Y, Xue CC, Helme R, Da Costa C, Zheng Z. Acupuncture for frequent migraine: a randomized, patient/assessor blinded, Controlled Trial with One-Year Follow-Up. Evid-Based Complement Altern Med ECAM. 2015;2015:920353.Google Scholar
  62. 62.
    Gu T, Lin L, Jiang Y, Chen J, D’Arcy RC, Chen M, et al. Acupuncture therapy in treating migraine: results of a magnetic resonance spectroscopy imaging study. J Pain Res. 2018;11:889–900.PubMedPubMedCentralGoogle Scholar
  63. 63.
    Happe S, Peikert A, Siegert R, Evers S. The efficacy of lymphatic drainage and traditional massage in the prophylaxis of migraine: a randomized, controlled parallel group study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2016;37(10):1627–32.Google Scholar
  64. 64.
    Safonov MI, Naprienko MV. Analysis of the efficacy of reflexology in the complex treatment of chronic migraine. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):22–5.PubMedGoogle Scholar
  65. 65.
    Imani N, Shams SA, Radfar M, Ghavami H, Khalkhali HR. Effect of applying reflexology massage on nitroglycerin-induced migraine-type headache: a placebo-controlled clinical trial. Agri Agri Algoloji Derneginin Yayin Organidir J Turk Soc Algol. 2018;30(3):116–22.Google Scholar
  66. 66.
    Daith Piercings 101 - Migraine Treatment [Internet]. American Migraine Foundation. [cited 2018 Sep 18]. Available from: https://americanmigrainefoundation.org/understanding-migraine/daith-piercings-101/. Accessed 17 Sept 2018
  67. 67.
    Blatchley C, Wilkins A. Daith Piercing, Vagus nerve stimulation and migraine prevention, 2018 Migraine Trust International Symposium, London 2018.Google Scholar
  68. 68.
    Cascio Rizzo A, Paolucci M, Altavilla R, Brunelli N, Assenza F, Altamura C, et al. Daith Piercing in a case of chronic migraine: a possible vagal modulation. Front Neurol [Internet]. 2017 Nov 27 [cited 2018 May 15];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711775/. Accessed 14 May 2018
  69. 69.
    Sansone E, Raggi A, Grignani E, Leonardi M, D’Amico D, Scaratti C, et al. Mindfulness meditation for chronic migraine in pediatric population: a pilot study. Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol. 2018;39(Suppl 1):111–3.Google Scholar
  70. 70.
    Wells RE, Phillips RS, Schachter SC, McCarthy EP. Complementary and alternative medicine use among US adults with common neurological conditions. J Neurol. 2010;257(11):1822–31.PubMedPubMedCentralGoogle Scholar
  71. 71.
    Aveni E, Bauer B, Ramelet A-S, Kottelat Y, Decosterd I, Finti G, et al. The attitudes of physicians, nurses, physical therapists, and midwives toward complementary medicine for chronic pain: a survey at an academic hospital. Explore N Y N. 2016 Oct;12(5):341–6.Google Scholar
  72. 72.
    Oinonen SM. Integrative medicine: a necessary component in completing treatment for my chronic migraines. Headache. 2017;57:809–811Google Scholar
  73. 73.
    Armstrong L, Gossard G. Taking an integrative approach to migraine headaches. J Fam Pract. 2016;65(3):165–76.PubMedGoogle Scholar
  74. 74.
    Cowan RP. CAM in the real world: you may practice evidence-based medicine, but your patients don’t. Headache. 2014;54(6):1097–102.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • Rebecca Erwin Wells
    • 1
    Email author
  • Justin Beuthin
    • 1
  • Laura Granetzke
    • 1
  1. 1.Department of NeurologyWake Forest Baptist HealthWinston-SalemUSA

Personalised recommendations